Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Not yet recruitingOBSERVATIONAL
Enrollment

176

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
ElderlyGeriatric AssessmentALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Interventions
PROCEDURE

Geriatric Assessment

This is a study held in all patients undergoing allogenic hematopoietic stem cell transplantation. Pre-transplant assessment: (1)Patients-related assessment: (a) Age; (b) Functional status (BADL score; IADL score; KPS score; ECOG PS score); (c) Comorbidities (HCT-CI score); (d) Nutritional Status (Body weight; BMI; NRS-2002; MNA-SF; MUST); (e) Psychological Status (SF36-MCS; GDS; PHQ-9; GAD-7); (f) Cognitive Function (MMSE; BMOC); (g) Social Support Level (MOS-SSS; MSPSS); (h) Total Number of Medications Used. (2) Disease-Related Factors Assessment: Primary Disease Diagnosis; ELN Risk Stratification (assessed only for AML patients); Disease Status. (3) Donor-Related Factors Assessment: Donor Age; Donor Sex; Donor-Recipient Blood Type Compatibility; Donor Type; DSA. (4) Treatment-Related Factors Assessment: Conditioning Regimen; GVHD Prophylaxis Regimen; Graft Type.

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT06946654 - Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT | Biotech Hunter | Biotech Hunter